380 related articles for article (PubMed ID: 36291618)
1. Alzheimer's Disease: Challenges and a Therapeutic Opportunity to Treat It with a Neurotrophic Compound.
Baazaoui N; Iqbal K
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291618
[TBL] [Abstract][Full Text] [Related]
2. Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer's disease.
Kazim SF; Iqbal K
Mol Neurodegener; 2016 Jul; 11(1):50. PubMed ID: 27400746
[TBL] [Abstract][Full Text] [Related]
3. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K
Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994
[TBL] [Abstract][Full Text] [Related]
4. Prevention of dendritic and synaptic deficits and cognitive impairment with a neurotrophic compound.
Baazaoui N; Iqbal K
Alzheimers Res Ther; 2017 Jun; 9(1):45. PubMed ID: 28655344
[TBL] [Abstract][Full Text] [Related]
5. Prevention of Amyloid-β and Tau Pathologies, Associated Neurodegeneration, and Cognitive Deficit by Early Treatment with a Neurotrophic Compound.
Baazaoui N; Iqbal K
J Alzheimers Dis; 2017; 58(1):215-230. PubMed ID: 28387677
[TBL] [Abstract][Full Text] [Related]
6. Prenatal to early postnatal neurotrophic treatment prevents Alzheimer-like behavior and pathology in mice.
Wei W; Wang Y; Liu Y; Dai CL; Tung YC; Liu F; Iqbal K
Alzheimers Res Ther; 2020 Aug; 12(1):102. PubMed ID: 32854771
[TBL] [Abstract][Full Text] [Related]
7. Neurotrophic Treatment Initiated During Early Postnatal Development Prevents the Alzheimer-Like Behavior and Synaptic Dysfunction.
Wei W; Liu Y; Dai CL; Baazaoui N; Tung YC; Liu F; Iqbal K
J Alzheimers Dis; 2021; 82(2):631-646. PubMed ID: 34057082
[TBL] [Abstract][Full Text] [Related]
8. Rescue of cognitive-aging by administration of a neurogenic and/or neurotrophic compound.
Bolognin S; Buffelli M; Puoliväli J; Iqbal K
Neurobiol Aging; 2014 Sep; 35(9):2134-46. PubMed ID: 24702821
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the Molecular Role of Brain-Derived Neurotrophic Factor in Alzheimer's Disease.
Girotra P; Behl T; Sehgal A; Singh S; Bungau S
J Mol Neurosci; 2022 Feb; 72(2):173-186. PubMed ID: 34424488
[TBL] [Abstract][Full Text] [Related]
10. Neurotrophic factors in Alzheimer's disease: pathogenesis and therapy.
Lübke JH; Idoon F; Mohasel-Roodi M; Alipour F; Hami J; Ehteshampour A; Mostafaee H; Sadeghi A
Acta Neurobiol Exp (Wars); 2021; 81(4):314-327. PubMed ID: 35014981
[TBL] [Abstract][Full Text] [Related]
11. Brain-Derived Neurotrophic Factor in Alzheimer's Disease: Risk, Mechanisms, and Therapy.
Song JH; Yu JT; Tan L
Mol Neurobiol; 2015 Dec; 52(3):1477-1493. PubMed ID: 25354497
[TBL] [Abstract][Full Text] [Related]
12. Brain-derived neurotrophic factor in Alzheimer's disease and its pharmaceutical potential.
Gao L; Zhang Y; Sterling K; Song W
Transl Neurodegener; 2022 Jan; 11(1):4. PubMed ID: 35090576
[TBL] [Abstract][Full Text] [Related]
13. In vitro validation of effects of BDNF-expressing mesenchymal stem cells on neurodegeneration in primary cultured neurons of APP/PS1 mice.
Song MS; Learman CR; Ahn KC; Baker GB; Kippe J; Field EM; Dunbar GL
Neuroscience; 2015 Oct; 307():37-50. PubMed ID: 26297896
[TBL] [Abstract][Full Text] [Related]
14. Intranasal delivery of BDNF rescues memory deficits in AD11 mice and reduces brain microgliosis.
Braschi C; Capsoni S; Narducci R; Poli A; Sansevero G; Brandi R; Maffei L; Cattaneo A; Berardi N
Aging Clin Exp Res; 2021 May; 33(5):1223-1238. PubMed ID: 32676979
[TBL] [Abstract][Full Text] [Related]
15. Genetic knockdown of brain-derived neurotrophic factor in 3xTg-AD mice does not alter Aβ or tau pathology.
Castello NA; Green KN; LaFerla FM
PLoS One; 2012; 7(8):e39566. PubMed ID: 22870188
[TBL] [Abstract][Full Text] [Related]
16. Low Levels of Brain-Derived Neurotrophic Factor Trigger Self-aggregated Amyloid β-Induced Neuronal Cell Death in an Alzheimer's Cell Model.
Tagai N; Tanaka A; Sato A; Uchiumi F; Tanuma SI
Biol Pharm Bull; 2020; 43(7):1073-1080. PubMed ID: 32612070
[TBL] [Abstract][Full Text] [Related]
17. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
[TBL] [Abstract][Full Text] [Related]
18. Elevated Tau Level in Aged Rat Cerebrospinal Fluid Reduced by Treatment with a Neurotrophic Compound.
Khatoon S; Chalbot S; Bolognin S; Puoliväli J; Iqbal K
J Alzheimers Dis; 2015; 47(3):557-64. PubMed ID: 26401692
[TBL] [Abstract][Full Text] [Related]
19. Environmental Enrichment Effects on the Brain-Derived Neurotrophic Factor Expression in Healthy Condition, Alzheimer's Disease, and Other Neurodegenerative Disorders.
Cutuli D; Landolfo E; Petrosini L; Gelfo F
J Alzheimers Dis; 2022; 85(3):975-992. PubMed ID: 34897089
[TBL] [Abstract][Full Text] [Related]
20. Amyloid beta soluble forms and plasminogen activation system in Alzheimer's disease: Consequences on extracellular maturation of brain-derived neurotrophic factor and therapeutic implications.
Angelucci F; Čechová K; Průša R; Hort J
CNS Neurosci Ther; 2019 Mar; 25(3):303-313. PubMed ID: 30403004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
